Verkazia™ (cyclosporine) – New orphan drug approval
June 24, 2021 - Santen Pharmaceutical announced the FDA approval of Verkazia (cyclosporine) ophthalmic emulsion 0.1%, for the treatment of vernal keratoconjunctivitis (VKC) in children and adults.
Download PDF
